Annual Report for FY 2025-26

21.09.2026 Hyderabad Corporate Compliance Dept. BSE Limited, P.J. Towers, Dalal Street, Mumbai 400001, Maharashtra Sub: Submission of Annual Report for the financial year 2025-26 Ref: Scrip Code: 540729 | Scrip ID: VANTABIO Dear Sir/Madam, Pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Notice of the 10th Annual General Meeting ("AGM") of the Company along with the Annual Report for the Financial Year 2025-26. The same has also been uploaded on the Companys website. This is for your information and for dissemination to general public. Thanking you, for VANTA BIOSCIENCE LIMITED DOPESH RAJA MULAKALA MANAGING DIRECTOR DIN: 01176660 Encl: As above VANTA BIOSCIENCE LIMITED 10th Annual Report Vanta Bioscience Limited 10th Annual Report FY 2025-26 Wednesday, September 30, 2026 at 10:00 A.M. At 197, Arun Khetarpal Road, Uma Nagar Colony, Sikh Village, Bowenpally, Secunderabad - 500009, Telangana, India. Table of Contents Sl.No. Particulars Page No. 1. Corporate Information 04 2. Notice of the 10th Annual General Meeting 05 3. Board's Report 15 4. Annexure to Board's Report 24 5. Management Discussion and Analysis Report 33 6. Independent Auditor's Report on Standalone Financial Statements 37 7. Standalone Balance Sheet 45 8. Standalone Statement of Profit and Loss 46 9. Standalone Cash Flows Statement 47 10. Notes to the Standalone Financial Statements 48 11. Independent Auditors' Report on Consolidated Financial Statements 62 12. Consolidated Balance Sheet 70 13. Consolidated Statement of Profit and Loss 71 14. Consolidated Cash Flows Statement 72 15. Notes to the Consolidated Financial Statements 73 16. Attendance Slip 89 17. Proxy Form 91 18. Route Map 93 VANTA BIOSCIENCE LIMITED 10th Annual Report Vanta Bioscience Limited 10th Annual Report FY 2025-26 Wednesday, September 30, 2026 at 10:00 A.M. At 197, Arun Khetarpal Road, Uma Nagar Colony, Sikh Village, Bowenpally, Secunderabad - 500009, Telangana, India. Table of Contents Sl.No. Particulars Page No. 1. Corporate Information 04 2. Notice of the 10th Annual General Meeting 05 3. Board's Report 15 4. Annexure to Board's Report 24 5. Management Discussion and Analysis Report 33 6. Independent Auditor's Report on Standalone Financial Statements 37 7. Standalone Balance Sheet 45 8. Standalone Statement of Profit and Loss 46 9. Standalone Cash Flows Statement 47 10. Notes to the Standalone Financial Statements 48 11. Independent Auditors' Report on Consolidated Financial Statements 62 12. Consolidated Balance Sheet 70 13. Consolidated Statement of Profit and Loss 71 14. Consolidated Cash Flows Statement 72 15. Notes to the Consolidated Financial Statements 73 16. Attendance Slip 89 17. Proxy Form 91 18. Route Map 93 VANTA BIOSCIENCE LIMITED 10th Annual Report VANTA BIOSCIENCE LIMITED 10th Annual Report VANTA BIOSCIENCE LIMITED Regd. Office: No.02/G/308/G, No.3/FF/SF/1-20-248, Umajay Complex, CORPORATE INFORMATION Rasoolpura, Secunderabad – 500 003, Telangana, India CIN: L74999TG2016PLC109280| Website: www.vantabio.com Contact No.: +91 40 6657 5454|Email ID: cs@vantabio.com Board of Directors NOTICE Mr. Dopesh Raja Mulakala (DIN: 01176660) : Managing Director Dr. Padmanabhuni Venkata Appaji (DIN: 02614167) : Non-Executive Independent Director Notice is hereby given that the 10th Annual General Meeting of the Shareholders of Vanta Bioscience Limited will be held on Dr. Gonuguntla Kathyayani (DIN: 07824881) : Non-Executive Independent Director Wednesday, September 30, 2026 at 10:00 AM at 197, Arun Khetarpal Road, Uma Nagar Colony, Sikh Village, Bowenpally, Secunderabad - 500009, Telangana, to transact the following businesses: Dr. Yogeswara Rao Danda (DIN: 00694803) : Non-Executive Independent Director ORDINARY BUSINESS: 1. To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements for the financial year ended KMPs March 31, 2026 along with the Reports of the Auditors and Board of Directors thereon. Mr. Dokka Venkata Sathya Murali : Chief Financial Officer 2. To appoint a director in place of Mr. Dopesh Raja Mulakala (DIN: 01176660), Managing Director of the Company, who Ms. Pooja Kothari : Company Secretary & Compliance Officer retires by rotation and being eligible, offers himself for re-appointment. Special Business: 3. Re-appointment of Mr. Dopesh Raja Mulakala (DIN: 01176660) as Managing Director of the Company Registered Office To consider and, if thought fit, to pass the following resolution as an Ordinary Resolution: Vanta Bioscience Limited RESOLVED THAT pursuant to the provisions of Sections 196, 197, 203 read with the Companies (Appointment and No.02/G/308/G, No.3/FF/SF/1-20-248, Umajay Complex, Remuneration of Managerial Personnel) Rules, 2014, Schedule V of the Companies Act, 2013, pursuant to the Rasoolpura, Secunderabad - 500 003, Telangana, India recommendation of Nomination and Remuneration Committee and subject to necessary approvals, if any, the consent of CIN: L74999TG2016PLC109280 | Website: www.vantabio.com the members be and is hereby accorded for the re-appointment of Mr. Dopesh Raja Mulakala (DIN: 01176660) as the Contact No.: +91 40 6657 5454 | Email ID: cs@vantabio.com Managing Director of the Company for another term of 3 years with effect from April 18, 2026 at a remuneration detailed ISIN: INE695X01011 below: i) Overall remuneration: Mr. Dopesh Raja Mulakala (DIN: 01176660) may be paid a remuneration (i.e. salary, perquisites Statutory Auditors and commission) upto Rs. 2,50,000/- (Rupees Two Lakh and Fifty Thousand Only) per month as may be decided by Mathesh & Ramana the Board. He shall also be provided with a Company car with driver, telephone instrument and a laptop and shall be Chartered Accountants eligible for reimbursement of expenses at actuals in accordance with the policy of the Company. In case of any 3-6-145, Himayatnagar, doubts/discrepancy/clarification that may arise with respect to payment of remuneration the same shall be determined Hyderabad – 500 029, Telangana and decided by the Board. ii) Minimum remuneration: In the event of inadequacy or absence of profits in any financial year, during the currency of Secretarial Auditors the tenure of his office, he shall be paid the above remuneration, as minimum remuneration in accordance with the Ms. Putcha Sarada provisions of Part II of Schedule V of the Act. Practicing Company Secretary iii) The Board shall have the discretion to determine whether any remuneration shall be payable to Mr. Dopesh Raja Hyderabad, Telangana Mulakala (DIN: 01176660) during the tenure of his appointment and, if so payable, to determine, revise, modify or vary from time to time the amount, composition, structure, mode and terms of payment thereof, subject to the provisions of Bankers the Companies Act, 2013 and such approvals as may be required. State Bank of India RESOLVED FURTHER THAT the Directors of the Company be and are hereby severally authorised to do all such acts SME Branch, Saifabad, things and deeds including but not limited to filing of requisite forms/ returns with the office of Registrar of Companies so as Hyderabad – 500 004, Telangana to bring this resolution into force." Registrar & Share Transfer Agents Bigshare Services Private Limited By order of the Board 306, Right Wing, Amrutha Ville Apts., For Vanta Bioscience Limited Somajiguda, Hyderabad – 500 082 Contact No. : 040 2337 4967 E-Mail :bsshyd@bigshareonline.com Sd/- Listed at Dopesh Raja Mulakala Managing Director SME Platform of BSE Ltd. DIN: 01176660 Scrip Code: 540729 | Scrip ID: VANTABIO 05.09.2026 Secunderabad VANTA BIOSCIENCE LIMITED 10th Annual Report VANTA BIOSCIENCE LIMITED 10th Annual Report VANTA BIOSCIENCE LIMITED Regd. Office: No.02/G/308/G, No.3/FF/SF/1-20-248, Umajay Complex, CORPORATE INFORMATION Rasoolpura, Secunderabad – 500 003, Telangana, India CIN: L74999TG2016PLC109280| Website: www.va [Showing first 8,000 characters — download PDF for full document]